Presentation
Transgene is a biotechnology company focused on designing and developing immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of two therapeutic vaccines (TG4001 for the treatment of HPV-positive cancers, and TG4050, an individualized therapeutic vaccine based on the myvac® platform) and two oncolytic viruses (TG6002 and BT-001, the first oncolytic virus based on the Invir.IO™ platform).
Contact
Address
Boulevard Gonthier d’Andernach | Parc d’innovation | CS80166 | 67405 Illkirch-Graffenstaden Cedex | FRANCE
Website
Targeted indications : Breast cancer, Lung cancer, Colorectal cancer, Stomach cancer, Head and neck cancers, Gastrointestinal cancers, Gynecological cancers, Genitourinary cancers, Skin cancer